Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.1K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.1K
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

2.7K
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
2.7K
Bacterial Cell Wall01:22

Bacterial Cell Wall

5.6K
The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
5.6K
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

59
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
59
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

66
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct molecular epidemiology and outcomes of carbapenem-resistant gram-negative infections in Lebanon: insights from the MDRO network.

BMC infectious diseases·2026
Same author

Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.

Open forum infectious diseases·2026
Same author

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

Antimicrobial agents and chemotherapy·2026
Same author

Empirical Antibiotic Activity and Outcomes in Pediatric Gram-Negative Bloodstream Infections: A Rank-based Composite Outcome Analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trial.

EBioMedicine·2026
Same author

Response to: 'Comment on 'Metagenomic next-generation sequencing: a game changer in the diagnosis of unique intraocular infections''.

Eye (London, England)·2026

Related Experiment Video

Updated: Apr 21, 2026

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
12:08

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium

Published on: February 14, 2022

3.6K

Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial.

Ritu Banerjee1, Lauren Komarow2, Yixuan Li2

  • 1Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.

JAMA
|April 18, 2026
PubMed
Summary
This summary is machine-generated.

Rapid antimicrobial susceptibility testing (AST) for gram-negative bacteria bloodstream infections (BSIs) showed no significant improvement in patient outcomes compared to standard methods. Further research is needed to determine the clinical impact of rapid AST in BSI management.

More Related Videos

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

9.2K
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

34.4K

Related Experiment Videos

Last Updated: Apr 21, 2026

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
12:08

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium

Published on: February 14, 2022

3.6K
Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

9.2K
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

34.4K

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Health Services Research

Background:

  • Novel blood culture diagnostics offer rapid antimicrobial susceptibility testing (AST) for bloodstream infections (BSIs).
  • The clinical impact of these rapid AST methods remains unclear, particularly in regions with high antimicrobial resistance.

Purpose of the Study:

  • To evaluate the clinical outcomes of rapid AST compared to standard AST in patients with gram-negative bacilli BSIs.
  • To assess the impact of rapid diagnostics in areas with significant antimicrobial resistance.

Main Methods:

  • An open-label randomized clinical trial involving 850 patients across 7 medical centers in Greece, India, Israel, and Spain.
  • Patients were randomized to either rapid phenotypic AST from positive blood cultures plus standard testing or standard testing alone.
  • The primary outcome was desirability of outcome ranking (DOOR) at 30 days, with secondary outcomes including mortality, hospitalization length, and time to effective antibiotic therapy.

Main Results:

  • Rapid AST was not superior to standard AST based on the primary DOOR outcome (48.8% favorable probability).
  • Median time to effective antibiotic therapy did not differ between groups, but time to antibiotic escalation/deescalation was faster with rapid AST.
  • In a subgroup with carbapenem-resistant infections, rapid AST showed a faster median time to effective therapy (9.5 vs 28 hours).

Conclusions:

  • Rapid blood culture AST did not demonstrate superiority over standard testing for gram-negative bacilli BSIs using the DOOR metric.
  • Findings suggest that while rapid AST may expedite antibiotic adjustments, its overall clinical superiority requires further investigation.
  • These results can inform clinical practice regarding the implementation of rapid susceptibility testing.